Pharvaris NV PHVS:NASDAQ

RT Quote | NASDAQ | USD
Last | 09/23/22 EDT
7.98UNCH (UNCH)
Volume
127
52 week range
7.86 - 27.50
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close7.98
  • 52 Week High27.50
  • 52 Week High Date06/17/22
  • 52 Week Low7.86
  • 52 Week Low Date09/23/22

Key Stats

  • Market Cap269.48M
  • Shares Out33.77M
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-44.54

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close7.98
  • 52 Week High27.50
  • 52 Week High Date06/17/22
  • 52 Week Low7.86
  • 52 Week Low Date09/23/22
  • Market Cap269.48M
  • Shares Out33.77M
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-44.54

RATIOS/PROFITABILITY

  • EPS (TTM)-1.77
  • P/E (TTM)-4.51
  • Fwd P/E (NTM)-3.37
  • EBITDA (TTM)-68.025M
  • ROE (TTM)-24.29%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)0.11%

EVENTS

  • Earnings Date11/08/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Pharvaris NV

 

Profile

MORE
Pharvaris BV is a Switzerland-based clinical-stage company. The activity of the Company focuses on producing oral bradykinin B2-receptor antagonists and is advancing new alternatives to injected therapies for all sub-types of hereditary angioedema (HAE).
Berndt Modig CPA
Chief Executive Officer, Co-Founder, Executive Director
Anna Nijdam
Head of Finance, Principal Accounting Officer
Address
J.H. Oortweg 21
Leiden
2333 CH
Netherlands

Top Peers

SYMBOLLASTCHG%CHG
IMRX
Immuneering Corp
10.56+0.31+3.02%
VXRT
Vaxart Inc
2.12+0.02+0.95%
OTLK
Outlook Therapeutics Inc
1.14-0.03-2.56%
GBIO
Generation Bio Co
4.67-0.11-2.30%
OPT
Opthea Ltd
5.90-0.04-0.67%